Sectors

YDES
YD Bio Limited Ordinary Shares
2.19
3 x 1.95
2 x 2.31
bid
ask
-
0.08
3.74%
12:07 PM
timesize
Ytd-82.08%
1y-82.52%
1.94
day range
2.54
1.70
52 week range
25.00
Open2.53Prev Close2.27Low1.94High2.54Mkt Cap160.79M
Vol35.44KAvg Vol126.45KEPS-0.12P/E-18.92Forward P/EN/A
BetaN/AShort Ratio0.77Inst. Own0.35%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg3.22200-d Avg8.711yr Est0.00
Upgrade / Downgrade
DateFirmActionFromTo
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2025-09-29Cerity Partners LLC32.41K429.06K0.05%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2025-09-29Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF20.86K276.21K0.03%